Cell line · CVCL_1567
NCI-H522
Cancer cell line, Homo sapiens. Lung adenocarcinoma. 62 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H522. Cell lines, record CVCL_1567. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1567
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H522
- Accession
- CVCL_1567
- RRID
- RRID:CVCL_1567
- Synonyms
- NCI.H522, H522, H-522, NCI-522, NCI522, NCIH522
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 58Y
- Category
- Cancer cell line
- Diseases
- Lung adenocarcinoma (NCIt C3512)
- Derived from
- Lung (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers62
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| E2A selectively regulates TGF-β-induced apoptosis in KRAS-mutant non-small cell lung cancer. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cell adhesion molecule-1 is a promising target for chimeric antigen receptors in lung adenocarcinoma. | Lung Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D. | J Virol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization. | PLoS Pathog | 2024 | Its Methods give the RRID and name the line | PubMed | |
| N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| HTS384 NCI60: The Next Phase of the NCI60 Screen. | Cancer Res | 2024 | Cellosaurus cites it, and its Methods give the RRID and name the line | PubMed | |
| Exosomes secreted by ST3GAL5high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| A tri-specific killer engager against mesothelin targets NK cells towards lung cancer. | Front Immunol | 2023 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 62
See all 62 papersRelatives0
None in this release.
Cell banks6
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-5810 | ATCC | |
| CLS | 305279 | CLS | |
| Hysigen | TCH-C607 | Hysigen | |
| KCLB | 25810 | Discontinued | Cellosaurus |
| KCLB | 90522 | KCLB | |
| NCI-DCTD | NCI-H522 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1567
GET https://conductscience.org/api/cell-lines/v1/CVCL_1567/papers?page=2